Package 51672-4227-8

Brand: clobazam

Generic: clobazam
NDC Package

Package Facts

Identity

Package NDC 51672-4227-8
Digits Only 5167242278
Product NDC 51672-4227
Description

120 mL in 1 BOTTLE (51672-4227-8)

Marketing

Marketing Status
Marketed Since 2021-06-30
Brand clobazam
Generic clobazam
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1fd3064f-ed73-9de1-e063-6294a90a0d97", "openfda": {"nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "unii": ["2MRO291B4U"], "rxcui": ["1366192"], "spl_set_id": ["fd1e63bf-496c-427c-83b7-6acabc00a5e5"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 mL in 1 BOTTLE (51672-4227-8)", "package_ndc": "51672-4227-8", "marketing_start_date": "20210630"}], "brand_name": "Clobazam", "product_id": "51672-4227_1fd3064f-ed73-9de1-e063-6294a90a0d97", "dosage_form": "SUSPENSION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "product_ndc": "51672-4227", "dea_schedule": "CIV", "generic_name": "clobazam", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clobazam", "active_ingredients": [{"name": "CLOBAZAM", "strength": "2.5 mg/mL"}], "application_number": "ANDA210978", "marketing_category": "ANDA", "marketing_start_date": "20210630", "listing_expiration_date": "20261231"}